
The Funding of Biopharmaceutical Research and Development
- 1st Edition - October 31, 2013
- Imprint: Woodhead Publishing
- Author: David R Williams
- Language: English
- Hardback ISBN:9 7 8 - 1 - 9 0 7 5 6 8 - 9 4 - 7
- eBook ISBN:9 7 8 - 1 - 9 0 8 8 1 8 - 3 8 - 6
The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceut… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quote- Presents a comprehensive view of the funding issues of R&D in this market sector, adopting a theory-to-practice approach
- A comprehensive and analytical review of the biopharmaceutical R&D literature and practice
- An overview of the various and competing/complementary theories of the firm and valuation methods as they apply to biopharmaceutical R&D
Dedication
List of figures and tables
Glossary
Preface
About the author
Chapter 1: Introduction to the biopharmaceutical market
Abstract:
1.1 Introduction
1.2 Synopsis of the development of the biopharmaceutical market sector
1.3 Global growth of research and biopharmaceuticals
1.4 Biopharmaceutical and healthcare value chain
1.5 Demand for biopharmaceuticals
1.6 Approval process
1.7 Generic medicines
1.8 Pricing of drugs
1.9 Summary
1.10 References
Chapter 2: Synopsis of theories of the firm and valuation methods
Abstract:
2.1 Introduction
2.2 The neoclassical perfect competition model
2.3 Industrial organization economics
2.4 Resource-based view of the firm
2.5 Innovation and entrepreneurship
2.6 Valuation
2.7 Real options
2.8 Final words on valuations
2.9 Corporate control
2.10 Summary
2.11 References
Chapter 3: Innovation and the merging of the pharmaceutical and biotechnology industries
Abstract:
3.1 Patents and patent protection
3.2 Standards and S-curves
3.3 Real options reasoning
3.4 Pro-innovation bias
3.5 Summary
3.6 References
Chapter 4: The funding of basic research and public–private partnerships
Abstract:
4.1 Introduction to research funding in the U.S.
4.2 Research funding in the European Union
4.3 Research funding in Asia
4.4 Technology transfer
4.5 Technology transfer offices
4.6 Bioclusters
4.7 Biocenters
4.8 Spill-overs and the diffusion of biopharmaceuticals
4.9 Summary
4.10 References
Chapter 5: Strategic alliances
Abstract:
5.1 Introduction to strategic alliances
5.2 Forms of strategic alliances
5.3 Models of the management of multiple alliances
5.4 Not all alliances are strategic
5.5 Opportunism in strategic alliances
5.6 Summary
5.6 References
Chapter 6: Angel and venture capital
Abstract:
6.1 Introduction to angel investors and venture capital
6.2 Venture capital staging
6.3 Venture capital history
6.4 Ownership structure
6.5 Venture capital and the entrepreneur
6.6 Venture capital around the world
6.7 Summary
6.8 References
Chapter 7: The initial public offering
Abstract:
7.1 An introduction to the initial public offering
7.2 A brief synopsis of the history of stock exchanges
7.3 The IPO process in the United States
7.4 IPOs around the U.S.
7.5 Research and development expenditures and financial condition
7.6 IPO performance
7.7 Venture capital involvement
7.8 IPO as exit
7.9 IPO activity around the world
7.10 Summary
7.11 References
Chapter 8: Conclusion
Abstract:
8.1: References
Index
- Edition: 1
- Published: October 31, 2013
- Imprint: Woodhead Publishing
- No. of pages: 284
- Language: English
- Hardback ISBN: 9781907568947
- eBook ISBN: 9781908818386
DW